OncoCyte Corporation (OCX) Balance Sheet Annual

OncoCyte Corporation

OCX (NASDAQ)

(%)

Financials
OncoCyte Corporation Balance Sheet Statement Annual

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2024 12-31	2023 12-31	2022 12-31	2021 12-31	2020 12-31	2019 12-31	2018 12-31	2017 12-31	2016 12-31	2015 12-31	2014 12-31	2013 12-31
Report Filing:	2025-03-24	2024-04-16	2023-04-12	2022-03-11	2021-03-19	2020-04-28	2019-04-01	2018-04-02	2017-02-27	2016-05-24	2014-12-31	2013-12-31
Total Current Assets	11.76	10.7	25.54	39.14	9.23	22.96	8.64	8.53	12.7	10.93	3.65	4.85
Cash and Short Term Investments	8.64	9.43	20.43	36.51	7.82	22.45	8.46	8.36	12.41	10.54	3.54	4.73
Cash & Equivalents	8.64	9.43	19.99	35.6	7.14	22.07	8.03	7.6	10.17	8	0.257	0.101
Short Term Investments	0	0	0.433	0.904	0.675	0.379	0.428	0.76	2.24	2.54	3.28	4.63
Receivables	1.61	0.484	2.01	1.44	0.203	0	0	0	0	0	0	0
Inventory	0.41	0	2.12	0.304	0	0	0	0	0	0	0	0
Other Current Assets	1.1	0.782	0.977	0.893	1.21	0.505	0.18	0.168	0.285	0.388	0.114	0.12
Total Assets	35.08	74.89	100.1	159.6	55.42	39.86	9.52	10.22	14.45	12.73	6.36	8.29
Total Non-Current Assets	23.32	64.19	74.56	120.4	46.19	16.9	0.876	1.69	1.75	1.81	2.71	3.44
Property, Plant and Equipment	2.76	5.44	10.85	8.53	6.52	3.73	0.614	0.822	0.688	0.576	0.118	0.148
Goodwill and Intangible Assets	14.61	56.59	61.63	109.9	24.2	0	0	0.746	0.988	1.23	1.47	1.71
Goodwill	0	0	0	18.68	9.19	0	0	0	0	0	0	0
Intangible Assets	14.61	56.59	61.63	91.25	15.01	0	0	0.746	0.988	1.23	1.47	1.71
Long Term Investments	0	0	1.7	1.7	13.42	10.96	0	0	0	0	0	-1.57
Deferred Tax Assets	0	0	-1.7	-1.7	0.118	0	0	0	0	0	1.11	1.57
Other Long Term Assets	5.96	2.16	2.07	1.96	1.94	2.21	0.262	0.12	0.075	0	0	1.57
Total Current Liabilities	7.28	7.19	12.11	14.12	9	4.44	5.56	4.45	4.28	2.31	7.43	4.67
Accounts Payable	2.28	0.953	1.25	1.81	0.432	0.469	0.166	0.175	0.422	0.285	0.144	0.103
Notes Payable/Short Term Debt	1.29	0.665	1.63	2.95	3.23	1.58	1.57	1.48	0.404	0	5.89	2.96
Tax Payables	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue	0	0	0	0	5.15	0	0	0	0	-0.847	0	0
Other Current Liabilities	3.7	5.58	9.22	9.36	0.178	2.39	3.83	2.8	3.45	2.88	1.4	1.61
Total Liabilities	47.35	49.3	65.8	94.35	21.94	9.02	6.09	5.81	4.58	2.31	7.43	4.67
Total Non-Current Liabilities	40.08	42.1	53.69	80.23	12.94	4.58	0.534	1.36	0.31	0	0	0
Total Long Term Debt	2.37	2.2	2.73	3.54	5.82	4.58	0.534	1.36	0.31	0	0	0
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non-Current	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	2.37	2.87	3.54	4.36	4.73	2.91	0.572	0.627	0.512	0	0	0
Other Long Term Liabilities	35.34	37.03	47.42	72.32	2.39	-2.91	-0.572	-0.627	-0.512	0	0	0
Total Equity	-12.27	25.59	34.29	65.22	33.48	30.84	3.42	4.4	9.86	10.42	-1.07	3.62
Non-Controlling Interest	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholders' Equity	-12.27	25.59	34.29	65.22	33.48	30.84	3.42	4.4	9.86	10.42	-1.07	3.62
Retained Earnings	-350.5	-289.9	-260.7	-187.8	-123.7	-93.75	-71.32	-54.68	-35.3	-24.13	-15.4	-10.41
Accumulated Other Earnings	0.021	0.049	0.039	0.037	0	0	0	-0.888	-0.654	-0.35	-0.822	-1.37
Common Stock	338.2	310.3	294.9	253	157.2	124.6	74.74	59.97	45.82	34.9	15.15	15.4
Preferred Stock	0	5.13	5.3	0	0	0	0	0	0	0	0	0
Additional Paid in Capital	0	0	-5.3	0	0	0	0	0	0	0	0	0
Total Liabilities & Total Equity	35.08	74.89	100.1	159.6	55.42	39.86	9.52	10.22	14.45	12.73	6.36	8.29
Total Liabilities & Shareholders' Equity	35.08	74.89	100.1	159.6	55.42	39.86	9.52	10.22	14.45	12.73	6.36	8.29
Total Investments	0	1.7	0.433	0.904	14.09	11.34	0.428	0.76	2.24	2.54	3.28	4.63
Total Debt	3.66	2.87	3.54	5.68	8.63	5.94	1.72	2.5	0.512	0.847	5.89	2.96
Net Debt	-4.97	-6.56	-16.45	-29.93	1.49	-16.14	-6.32	-5.1	-9.66	-7.15	5.63	2.86

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

OncoCyte Corporation Balance Sheet Statement Annual